NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,088 filers reported holding NOVARTIS A G in Q3 2019. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,486,545 | +19.0% | 14,594 | +17.9% | 0.06% | +11.5% |
| Q2 2023 | $1,248,963 | +14.3% | 12,377 | +4.2% | 0.05% | -1.9% |
| Q1 2023 | $1,092,316 | +1.4% | 11,873 | 0.0% | 0.05% | -18.5% |
| Q4 2022 | $1,077,119 | +43.8% | 11,873 | +20.4% | 0.06% | +32.7% |
| Q3 2022 | $749,000 | -10.1% | 9,859 | 0.0% | 0.05% | -3.9% |
| Q2 2022 | $833,000 | +298.6% | 9,859 | +313.9% | 0.05% | +363.6% |
| Q1 2022 | $209,000 | +0.5% | 2,382 | 0.0% | 0.01% | -8.3% |
| Q4 2021 | $208,000 | -45.3% | 2,382 | -42.8% | 0.01% | -47.8% |
| Q2 2021 | $380,000 | +7.0% | 4,167 | +0.4% | 0.02% | +4.5% |
| Q1 2021 | $355,000 | +50.4% | 4,152 | +66.3% | 0.02% | +57.1% |
| Q4 2020 | $236,000 | +15.1% | 2,497 | +6.2% | 0.01% | +7.7% |
| Q3 2020 | $205,000 | 0.0% | 2,352 | 0.0% | 0.01% | -13.3% |
| Q2 2020 | $205,000 | -8.1% | 2,352 | 0.0% | 0.02% | +7.1% |
| Q4 2019 | $223,000 | +8.3% | 2,352 | -0.7% | 0.01% | +7.7% |
| Q3 2019 | $206,000 | +2.5% | 2,369 | +7.5% | 0.01% | +8.3% |
| Q2 2019 | $201,000 | -17.6% | 2,203 | -13.1% | 0.01% | -14.3% |
| Q1 2019 | $244,000 | +8.9% | 2,535 | -3.1% | 0.01% | 0.0% |
| Q4 2018 | $224,000 | -2.6% | 2,615 | -14.1% | 0.01% | +7.7% |
| Q2 2018 | $230,000 | -99.9% | 3,043 | +9.1% | 0.01% | +8.3% |
| Q1 2018 | $225,410,000 | -3.9% | 2,788 | -0.2% | 0.01% | 0.0% |
| Q4 2017 | $234,584,000 | -29.0% | 2,794 | -27.4% | 0.01% | -33.3% |
| Q3 2017 | $330,523,000 | +3.0% | 3,850 | +0.1% | 0.02% | 0.0% |
| Q2 2017 | $320,942,000 | +12.4% | 3,845 | 0.0% | 0.02% | +5.9% |
| Q1 2017 | $285,568,000 | +40.7% | 3,845 | +49.6% | 0.02% | +30.8% |
| Q3 2016 | $202,927,000 | -4.3% | 2,570 | 0.0% | 0.01% | -13.3% |
| Q2 2016 | $212,051,000 | +4.3% | 2,570 | +17.1% | 0.02% | 0.0% |
| Q4 2015 | $203,296,000 | -11.3% | 2,194 | -12.0% | 0.02% | -6.2% |
| Q3 2015 | $229,248,000 | -6.5% | 2,494 | 0.0% | 0.02% | +14.3% |
| Q2 2015 | $245,260,000 | +3.9% | 2,494 | +4.2% | 0.01% | +7.7% |
| Q1 2015 | $236,072,000 | +16.1% | 2,394 | +9.1% | 0.01% | +8.3% |
| Q4 2014 | $203,296,000 | – | 2,194 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |